Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia

Clinical trial NCT00265382 · TERMINATED

Trial details

NCT number

NCT00265382

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Status

TERMINATED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2006-06-01

Primary completion

2009-06-01

Enrollment

221

View on ClinicalTrials.gov